Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

24.76USD
1:10pm EST
Change (% chg)

$-0.71 (-2.79%)
Prev Close
$25.47
Open
$25.50
Day's High
$25.50
Day's Low
$24.48
Volume
33,320
Avg. Vol
130,767
52-wk High
$26.75
52-wk Low
$12.10

RGEN.OQ

Chart for RGEN.OQ

About

Repligen Corporation is a United States-based life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. The Company manufactures Protein A, a critical reagent used to manufacture monoclonal antibody-based therapeutics. It also supplies... (more)

Overall

Beta: 1.17
Market Cap(Mil.): $833.42
Shares Outstanding(Mil.): 32.72
Dividend: --
Yield (%): --

Financials

  RGEN.OQ Industry Sector
P/E (TTM): 70.84 39.87 40.63
EPS (TTM): 0.36 -- --
ROI: 10.76 18.96 18.22
ROE: 11.08 19.75 19.13
Search Stocks

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $102.20 +0.11
Novartis AG (NOVN.VX) CHF88.70 -0.15
Roche Holding Ltd. (ROG.VX) CHF251.70 -5.60
Merck & Co., Inc. (MRK.N) $62.05 -0.51
Sanofi SA (SASY.PA) €81.99 +0.11
Amgen, Inc. (AMGN.OQ) $156.45 -2.44
Gilead Sciences, Inc. (GILD.OQ) $103.57 -1.46
Incyte Corporation (INCY.OQ) $82.71 -0.36

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks